- Home
- RELX vs COR Comparison
RELX vs COR Comparison
Compare RELX & COR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RELX | COR |
|---|---|---|
| Founded | 1903 | 2001 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Other Pharmaceuticals |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 63.5B | 59.1B |
| IPO Year | 2007 | 2001 |
Fundamental Metrics
Financial Performance| Metric | RELX | COR |
|---|---|---|
| Price | $39.01 | $326.15 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 14 |
| Target Price | $53.35 | ★ $369.08 |
| AVG Volume (30 Days) | ★ 2.1M | 1.0M |
| Earning Date | 07-23-2026 | 11-04-2026 |
| Dividend Yield | ★ 2.28% | 0.73% |
| EPS Growth | N/A | ★ 5.71 |
| EPS | N/A | ★ 15.21 |
| Revenue | N/A | ★ $321,332,819,000.00 |
| Revenue This Year | $4.92 | $4.89 |
| Revenue Next Year | $6.69 | $4.35 |
| P/E Ratio | ★ $20.27 | $21.71 |
| Revenue Growth | N/A | ★ 9.31 |
| 52 Week Low | $27.57 | $244.82 |
| 52 Week High | $45.73 | $377.54 |
Technical Indicators
Market Signals| Indicator | RELX | COR |
|---|---|---|
| Relative Strength Index (RSI) | 63.78 | 50.09 |
| Support Level | $32.38 | $299.24 |
| Resistance Level | N/A | $336.33 |
| Average True Range (ATR) | 0.71 | 5.87 |
| MACD | 0.28 | -0.38 |
| Stochastic Oscillator | 72.19 | 40.06 |
Price Performance
Historical ComparisonAbout RELX RELX PLC PLC
RELX is a developer of information-based analytics and decision tools designed to support research, risk assessment, legal work, and business operations. The company offers data analytics, scientific and technical information resources, legal research tools, and event management platforms. This enables professionals, researchers, legal teams, and businesses to make informed decisions and improve operational efficiency.
About COR Cencora Inc.
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.